High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer.
Eva PhilipsonCecilia EngströmPeter NarediJohan Bourghardt FagmanPublished in: BMC cancer (2022)
Our results show that high p62 protein expression in tumor cells is associated with shorter survival following pancreatic tumor resection. This association supports a role for p62 as a prognostic marker in patients with PDAC treated by primary surgery.